---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-078337"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-06-26T21:30:25+00:00"
generated_at: "2026-06-26T21:32:11.019310+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics regains Nasdaq minimum bid price compliance, delisting risk removed

## Summary
- Received Nasdaq letter on June 26, 2026 confirming compliance with bid price rule 5550(a)(2).
- Closing bid price was $1.00 or greater for ten consecutive business days from June 11-25, 2026.
- Prior delisting notice from February 18, 2026 for failing minimum bid price is now closed.
- Common stock (OTLK) remains listed on Nasdaq Capital Market without further action needed.

## SEC filing metadata
- accession: 0001104659-26-078337
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-06-26T21:30:25+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/0001104659-26-078337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/tm2619105d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-078337
- JSON: https://secwatch.observer/filing/0001104659-26-078337.json
- Plain text: https://secwatch.observer/filing/0001104659-26-078337.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.